Search Results - technology+classifications+%3e+life+sciences+%3e+biomarkers

26 Results Sort By:
Personalized Medicine Software for Generating and Analyzing Genomic Sequence
UA21-131 and UA21-132 Two Patents Pending for SYSTEMS AND METHODS FOR GENERATING AND ANALYZING A CUSTOMIZED GENOMIC SEQUENCE FOR THERAPEUTIC APPLICATIONS Software: Proof of concept software funded by Tech Launch Arizona developed by a software company is fully functional and creates consistent accurate results. MAXX Py The MAXX.py script generates...
Published: 11/2/2021   |   Inventor(s): Adam Grant
Keywords(s):  
Category(s): Technology Classifications > Software & Information Technology > Health IT, Technology Classifications > Healthcare Portfolios > Oncology, Technology Classifications > Life Sciences > Biomarkers, Technology Classifications > Life Sciences > Diagnostics
Blood Biomarker for the Diagnosis and Treatment of Chronic Inflammation in the Brain in the Days and Weeks after Stroke
This invention comprises a method of identifying chronic inflammation in the day(s), weeks, or months after a stroke by measuring matrix metalloproteinase-12 (MMP-12) in a patient to determine whether therapeutic intervention is required to help immune cells process lipid debris after stroke to reduce secondary neurodegeneration. MMP-12 is a protein...
Published: 6/16/2021   |   Inventor(s): Kristian Doyle
Keywords(s):  
Category(s): Technology Classifications > Healthcare Portfolios > Immunology, Autoimmune & Inflammation, Technology Classifications > Healthcare Portfolios > Neurology, Technology Classifications > Healthcare Portfolios > Neurology > CNS & Neurosciences, Technology Classifications > Life Sciences > Biomarkers, Technology Classifications > Life Sciences > Diagnostics, Technology Classifications > Research Tools > Protein
Biomarker for Patient Stratification for Treatment of Cognitive Impairment in Patients with Vascular Contributions to Cognitive Impairment
This technology has found a serum biomarker that is efficacious in stratifying patients with vascular contributions to cognitive impairment and dementia (VCID) and Alzheimer’s disease related dementias (ADRD). This biomarker was able to indicate patients with high levels of VCID that are well suited for treatment with angiotensin peptides. Background: Worldwide,...
Published: 12/2/2020   |   Inventor(s): Meredith Hay, John Konhilas, Christina Hoyer-Kimura, Thomas Beach, Geidy Serrano, Eric Reiman
Keywords(s):  
Category(s): Technology Classifications > Life Sciences > Biomarkers, Technology Classifications > Life Sciences > Diagnostics
Diagnostic for Monitoring Response to Immunotherapies for Gynecologic Cancer
This invention is a collection of immunological checkpoint proteins and physiological markers to diagnose and potentially monitor treatments for cervical cancer. This biomarker panel would be taken using the cervicovaginal lavage method which is a less invasive than other sampling method for cervical cancer. This diagnostic test could be used not only...
Published: 10/16/2019   |   Inventor(s): Melissa Herbst-Kralovetz, Pawel Laniewski
Keywords(s):  
Category(s): Technology Classifications > Healthcare Portfolios > Oncology, Technology Classifications > Healthcare Portfolios > Women's Health, Technology Classifications > Life Sciences > Biomarkers, Technology Classifications > Life Sciences > Diagnostics
Lipid Biomarkers for Cancer Screening and Monitoring
This invention relates to mechanisms and biomarkers for early detection of potentially aggressive cancers. These biomarkers are useful in determining the aggressiveness and drug resistance of existing cancers. Background: There is a need for a better, more convenient way to detect cancers to help reduce unnecessary biopsies and negative treatment...
Published: 9/5/2019   |   Inventor(s): Floyd Chilton, Ashley Snider, Justin Snider
Keywords(s):  
Category(s): Technology Classifications > Life Sciences > Biomarkers
Members of the WNT Signaling Pathway as Predictive Markers and Therapeutic Targets in Glioblastoma Multiforme
This technology is a set of biomarkers to predict radiotherapy and chemotherapy outcomes in individual Glioblastoma Multiforme patients to better assess their prognosis and therapy. Background: Glioblastoma Multiforme (GBM) is the most aggressive form of brain cancer and is currently treated through surgical intervention, chemotherapy and radiotherapy....
Published: 1/9/2019   |   Inventor(s): Eric Weterings, Baldassarre Stea, Daruka Mahadevan, Christopher Morrison, Michael Hammer
Keywords(s):  
Category(s): Technology Classifications > Healthcare Portfolios > Oncology, Technology Classifications > Life Sciences > Biomarkers
Diagnostic Analyte to Enrich LINE-1 and Detect LINE-1 Driven Oncologic Disease
This invention is a biomarker model, in which the biomarker detected can be used as a companion diagnostic or for screening and diagnosis of a variety of cancers. The model includes a novel liquid biopsy process that accurately measures biomarkers from blood samples by enriching for cell-derived vesicles shed directly from affected tissues. The data...
Published: 1/3/2019   |   Inventor(s): Kenneth Ramos, Emma Bowers, Patrick Silva, Brian Mckay
Keywords(s):  
Category(s): Technology Classifications > Healthcare Portfolios, Technology Classifications > Healthcare Portfolios > Oncology, Technology Classifications > Life Sciences > Biomarkers
Biomarker to Assess Risk For Skin Cancer Development
This technology is a diagnostic test that can help assess a patient's risk for developing skin cancer by measuring biomarker levels under specified conditions. Additionally, the test can help determine prophylactic treatment for an individual at risk of developing skin cancer. Background: Skin cancer is the most common type of cancer among the...
Published: 12/10/2018   |   Inventor(s): Clara Curiel, Amanda Fern Baker, Sally Dickinson, Emmanuel Petricoin III
Keywords(s):  
Category(s): Technology Classifications > Healthcare Portfolios > Dermatology, Technology Classifications > Life Sciences > Biomarkers, Technology Classifications > Life Sciences > Diagnostics
Measuring Edema and Body Composition in Heart Failure Using NMR-MRI
This invention is a method of utilizing Nuclear Magnetic Resonance-Magnetic Resonance Imaging (NMR-MRI) technology to assess and diagnose patients with heart dysfunction, heart failure (HF) and those at risk of developing heart dysfunction. It assesses a panel of biomarkers including edema and body composition that will then allow physicians to recommend...
Published: 11/8/2018   |   Inventor(s): Guy Reed, Inna Gladysheva, Ryan Sullivan, Radhika Mehta
Keywords(s):  
Category(s): Technology Classifications > Healthcare Portfolios > Heart and Vascular, Technology Classifications > Life Sciences > Biomarkers, Technology Classifications > Life Sciences > Therapeutics
Leukocyte RNA Expression: A Novel Neurosurgical Genomics Technique for Predicting Seizure-Free Outcome following Stereotactic Laser Amygdalohippocampotomy
This technology provides a novel set of gene-based biomarkers to predict seizure free results in Stereotactic Laser Amygdalohippocampotomy (SLAH) for epileptic patients. These biomarkers are based on leukocyte RNA expression so the prognosis can be easily done by a blood draw instead of a brain biopsy. Background: Drug resistant epilepsy patients...
Published: 10/10/2018   |   Inventor(s): Martin Weinand, Ryan Sprissler, Michael Hammer
Keywords(s):  
Category(s): Technology Classifications > Healthcare Portfolios > Neurology, Technology Classifications > Life Sciences > Biomarkers
1 2 3